Insider Transactions in Q4 2020 at Xtant Medical Holdings, Inc. (XTNT)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Nov 17 2020	Matthew Rizzo Director	BUY Exercise of in-the-money or at-the-money derivatives securities	Indirect	4,800,000 +2.6%	$0 $0.01 P/Share
Nov 17 2020	Michael Eggenberg Director	BUY Exercise of in-the-money or at-the-money derivatives securities	Indirect	4,800,000 +2.6%	$0 $0.01 P/Share
Nov 17 2020	Orbimed Advisors LLC Director	BUY Exercise of in-the-money or at-the-money derivatives securities	Indirect	4,800,000 +2.6%	$0 $0.01 P/Share
Nov 15 2020	Sean E Browne President and CEO	BUY Grant, award, or other acquisition	Direct	1,468,859 +44.96%	-
Oct 01 2020	Matthew Rizzo Director	BUY Grant, award, or other acquisition	Indirect	58,754,394 +45.46%	$58,754,394 $1.07 P/Share
Oct 01 2020	Michael Eggenberg Director	BUY Grant, award, or other acquisition	Indirect	58,754,394 +45.46%	$58,754,394 $1.07 P/Share
Oct 01 2020	Orbimed Advisors LLC Director	BUY Grant, award, or other acquisition	Indirect	58,754,394 +45.46%	$58,754,394 $1.07 P/Share

Receive a notification when an Institution or Guru buys or sells XTNT shares.

Notify only if

Value

Get notified when an Xtant Medical Holdings, Inc. insider buys or sells XTNT shares.

Notify only if

Operation

Value

Type

Receive news related to Xtant Medical Holdings, Inc.